Company news
Boule Diagnostics Ab (OMXSTO:BOUL) news
Every Boule Diagnostics Ab press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Boule Diagnostics Appoints Johan Folkunger As New CEO
June 18, 2026
Boule Diagnostics Appoints Simonetta Tumbiolo As Interim CEO
May 29, 2026
Bulletin from the Annual General Meeting May 13, 2026 in Boule Diagnostics
May 13, 2026
BOUL: Organic growth and positive cash flow achieved despite currency headwinds and lower sales
April 28, 2026
Boule Diagnostics – Invitation to presentation of the interim report Q1 2026
April 27, 2026
BOUL: Revenue fell 12% amid restructuring, but operational improvements and portfolio expansion drive future growth
February 11, 2026
Boule Diagnostics – Invitation to presentation of the Q4 report 2025
February 6, 2026
Boule Diagnostics Renews, Expands Global Supply Agreement
January 21, 2026
Boule Diagnostics Appoints Michael Af Winklerfelt As CFO
December 30, 2025
Boule Diagnostics Selected As Provider In Tender In Italy
December 22, 2025
Boule Diagnostics CEO Torben Nielsen To Leave Company
December 5, 2025
BOUL: Organic growth and strong instrument sales drive improved cash flow amid margin pressure
October 24, 2025
Boule Diagnostics CFO Leaves Company
October 13, 2025
BOUL: Instrument sales surged 17% but lower prices and costs led to margin decline; cash flow turned positive
July 18, 2025
BOUL: Sales fell 25% YoY, but margins improved and OEM growth offset hematology weakness
April 28, 2025
BOUL: Margins improved and cost savings realized, with OEM growth and new U.S. distribution boosting outlook
February 11, 2025
BOUL: Sales declined, but margins and EBIT improved amid restructuring and strong OEM growth
October 25, 2024
BOUL: Sales declined but margins improved; restructuring aims to boost profitability
July 22, 2024